Drugs / Pemetrexate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00705549 | Feb 2008 → Sep 2011 | non-small cell lung carcinoma | Hellenic Oncology Research Group | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pemetrexate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00705549 ↗ |
| Route | Intravenous | “Pemetrexate I.V 500mg/m2 on Day 1” NCT00705549 ↗ |